Rare and Autoinflammatory Diseases [ACR22] Rare and Autoinflammatory Diseases 29 Nov 20226 Dec 2022 Author: Francesca Crisafulli Direskeneli et al. (2231) retrospectively investigated the rate of new major organ involvement and/or relapses during follow-up in 440 patients with Behçet disease (BD) under immunosuppressive treatment…
Basic Research [ACR22] Basic Research 29 Nov 20226 Dec 2022 Author: Silvia Piantoni Izuka et al (0586) proposed a new approach of classification of the systemic immune-mediated diseases based on the associated immune cells, detected by flow cytometry. They have…
Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) [ACR22] Systemic Lupus Erythmatosus and Antiphospholipid Syndrome 29 Nov 20226 Dec 2022 Author: Cristiana Sieiro Santos Luong et al. (0320) described the use of metabolomic analysis of metabolites to identify biomarkers of disease activity or adverse pregnancy outcomes (APO) in SLE. Low-density…
Imaging [ACR22] Imaging 29 Nov 20226 Dec 2022 Author: Manouk de Hooge Wittoek et al. (2207) investigated the structural sonographic features of joints and tendons (right shoulder, hip, knee, ankle, first metatarsophalangeal joint (MTP1), elbow, wrist and second…
Rheumatoid arthritis II - therapeutic [ACR22] Rheumatoid Arthritis II – Clinical (Therapeutic) 29 Nov 20226 Dec 2022 Author: Daliya Pencheva Emery et al (L03) introduced the concept of stimulating human programmed cell death protein 1 (PD-1) as a new rheumatoid arthritis (RA) treatment. In a Phase 2a,…
Rheumatoid Arthritis [ACR22] Rheumatoid Arthritis I – Clinical (Non-therapeutic) 29 Nov 20226 Dec 2022 Author: Emanuele Bozzalla Cassione Leuchten et al (0265) analyzed the impact of synovitis in ankle and MTP joints on RA score and disease activity states across 7,577 visits. Foot joints…
Paediatric Rheumatology [ACR22] Paediatric Rheumatology 29 Nov 20226 Dec 2022 Author: Thomas Renson Ramanan et al (2210) presented phase 3 efficacy and safety data of baricitinib in 220 (non-systemic) juvenile idiopathic arthritis (JIA) patients. 63.5% of the patients achieved a…
Metabolic and Crystal Arthropathies [ACR22] Metabolic and Crystal Arthropathies 29 Nov 20226 Dec 2022 Author: Diego Benavent Botson et al (0001) assessed the efficacy and safety of pegloticase (PEGylated uricase) with methotrexate (MTX) vs placebo (PBO) as co-therapy, in the MIRROR RCT trial. Efficacy…
Spondyloarthritis II - therapeutic [ACR22] Spondyloarthritis II – Therapeutic 29 Nov 20226 Dec 2022 Author: Jean-Guillaume Letarouilly Baraliakos et al. (0420) studied the differences in the velocity and magnitude of NSAID response velocity in patients with established bDMARD naïve axSpA versus patients with other,…
Spondyloarthritis [ACR22] Spondyloarthritis I – Non-therapeutic 29 Nov 20226 Dec 2022 Author: Jean-Guillaume Letarouilly Sieiro Santos et al. (0373) developed a prognostic outcome score for patients with uveitis associated with SpA (SpA-U) and determine factors associated with adverse outcomes in uveitis…